+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Factor IX Complex Concentrate Market - Global Forecast 2026-2032- Product Image
Factor IX Complex Concentrate Market - Global Forecast 2026-2032- Product Image
Sale

Factor IX Complex Concentrate Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6142004
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Factor IX Complex Concentrate Market is projected to reach USD 1.33 Billion in 2026. It is expected to continue growing at a CAGR of 10.42%, reaching USD 2.41 Billion by 2032.

Factor IX Complex Concentrate: Executive Overview

Factor IX complex concentrates are plasma-derived or recombinant hemostatic therapies used to prevent and control bleeding associated with factor IX deficiency, including hemophilia B. Their clinical value depends on reliable diagnosis, appropriate dosing, safe administration, and continuity of treatment. The landscape is shaped by evolving standards of care, regulatory oversight, supply resilience, and access to specialist hematology services.

Treatment Pathways Are Shifting Toward Personalized, Proactive Care

Care is moving from episodic treatment alone toward individualized prophylaxis, home-based administration, and closer monitoring of bleeding patterns. Extended half-life products, improved infusion practices, and broader use of patient-specific pharmacokinetic assessment can reduce treatment burden for suitable patients. At the same time, safety expectations remain high, with continued attention to inhibitor development, infectious-disease controls for plasma-derived products, cold-chain management, and traceability.

Artificial Intelligence Supports Diagnosis, Dosing, and Supply Reliability

Artificial intelligence can contribute to earlier recognition of inherited bleeding disorders by identifying patterns in clinical records, laboratory results, and family histories. In established care, analytical tools may help estimate patient-specific dosing needs, detect adherence challenges, identify unusual bleeding activity, and support pharmacovigilance. AI can also improve inventory planning and distribution monitoring, but its use requires representative data, clinician oversight, explainability, privacy safeguards, and validation against clinically meaningful outcomes.

Regional Insights: Access Depends on Infrastructure, Standards, and Funding

North America generally combines specialist capacity, established diagnostic networks, and home-infusion pathways, while reimbursement rules and product access differ by jurisdiction. Europe benefits from coordinated clinical guidance and strong regulatory systems, although national procurement and reimbursement arrangements create variation. Asia-Pacific includes advanced treatment systems alongside settings where diagnosis, factor availability, and trained personnel remain uneven. Latin America continues to face differences in public-sector funding, treatment-center coverage, and supply continuity. In the Middle East, specialized centers and national health programs coexist with variable procurement and referral capacity. Africa’s priorities include earlier diagnosis, laboratory strengthening, reliable product access, and expansion of multidisciplinary hemophilia care.

Group Insights: Policy Alignment Can Improve Continuity of Care

ASEAN members face diverse health-system capabilities, making regional collaboration on diagnosis, procurement, training, and treatment standards particularly relevant. BRICS countries encompass substantial differences in domestic manufacturing, public provision, regulatory pathways, and specialist coverage, with cooperation potentially supporting resilient access. The European Union benefits from shared scientific and regulatory frameworks, while national reimbursement decisions continue to shape patient experience. G7 health systems generally have mature specialist infrastructure but still address affordability, workforce capacity, and equitable access. GCC countries can leverage centralized health planning and specialist networks, while continued attention to local workforce development and referral coordination is important. NATO members span varied health systems, so interoperability, emergency preparedness, and continuity planning remain useful considerations.

Country Insights: National Systems Shape Diagnosis and Treatment Availability

Australia and Canada rely on specialized treatment networks across geographically dispersed populations, making telehealth, logistics, and coordinated referral pathways important. Brazil, Mexico, India, China, Russia, and South Korea reflect different combinations of public programs, domestic production, regulatory processes, and urban-rural access gaps. Japan, France, Germany, Italy, Spain, and the United Kingdom have established hematology expertise and structured care pathways, while procurement, reimbursement, and treatment-center organization differ nationally. In the United States, advanced specialty care and home treatment are supported by a complex payer and provider environment. Across all listed countries, priorities include timely genetic and laboratory diagnosis, uninterrupted supply, patient education, inhibitor surveillance, and equitable access beyond major metropolitan centers.

Industry Priorities: Build Trust Through Resilient, Patient-Centered Care

Leaders should strengthen end-to-end supply resilience through diversified sourcing, validated cold-chain processes, inventory visibility, and contingency planning. Clinical strategies should support individualized treatment, shared decision-making, home-care education, and outcome tracking rather than focusing only on product availability. Organizations should invest in diagnostic partnerships, specialist training, pharmacovigilance, and clear communication about product characteristics. Digital and AI initiatives should begin with defined clinical use cases, high-quality data governance, human review, and measurable safety outcomes. Collaboration with public agencies, treatment centers, patient organizations, and logistics partners can help address regional disparities and improve continuity of care.

Research Methodology: Evidence-Led Assessment of Care and Access Factors

This executive summary is based on a qualitative assessment of the Factor IX complex concentrate landscape using established clinical, regulatory, public-health, and health-system considerations. The analysis organizes evidence around treatment pathways, product safety, diagnosis, access, infrastructure, policy, supply continuity, and digital-health applications. Regional, group, and country discussions are comparative and directional; they do not constitute market estimates, forecasts, or claims of uniform conditions within any geography. Interpretations should be updated against current regulatory decisions, clinical guidelines, procurement policies, and country-specific evidence.

Conclusion: Durable Progress Requires Reliable Products and Coordinated Systems

The future of Factor IX complex concentrate care will depend on more than therapeutic innovation. Earlier diagnosis, individualized prophylaxis, safe administration, resilient supply chains, skilled multidisciplinary teams, and equitable financing must advance together. Artificial intelligence may strengthen decision support and operational visibility when responsibly governed, but clinical accountability remains essential. Leaders that align innovation with patient needs, evidence, and health-system realities will be better positioned to improve continuity and quality of care across diverse settings.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Factor IX Complex Concentrate Market, by Product Type
7.1. Introduction
7.2. Extended Half Life
7.2.1. Albumin Fusion
7.2.2. Fc Fusion
7.2.3. Pegylated
7.3. Standard Half Life
7.3.1. Plasma Derived
7.3.1.1. Factor Ix Complex Concentrate
7.3.1.2. Prothrombin Complex Concentrate
7.3.2. Recombinant
8. Factor IX Complex Concentrate Market, by Indication
8.1. Introduction
8.2. On Demand Treatment
8.2.1. Major Bleeds
8.2.1.1. Gastrointestinal Bleeds
8.2.1.2. Intracranial Hemorrhage
8.2.1.3. Joint Bleeds
8.2.2. Minor Bleeds
8.3. Perioperative Management
8.4. Prophylaxis
8.4.1. Primary Prophylaxis
8.4.2. Secondary Prophylaxis
9. Factor IX Complex Concentrate Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.2.1. Inpatient Pharmacy
9.2.2. Outpatient Pharmacy
9.3. Retail Pharmacies
9.3.1. Community Pharmacy
9.3.2. Mail Order Pharmacy
10. Factor IX Complex Concentrate Market, by End User
10.1. Introduction
10.2. Clinics
10.2.1. Ambulatory Infusion Centers
10.2.2. General Clinics
10.3. Hemophilia Treatment Centers
10.3.1. Comprehensive Care Centers
10.3.2. Specialized Clinics
10.4. Home Care Settings
10.4.1. Caregiver Administration
10.4.2. Self Infusion
10.5. Hospitals
10.5.1. Secondary Care Hospitals
10.5.2. Tertiary Care Hospitals
11. Factor IX Complex Concentrate Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Factor IX Complex Concentrate Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Factor IX Complex Concentrate Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Aptevo BioTherapeutics LLC
15.2. Bayer AG
15.3. Bio Products Laboratory
15.4. BioMarin Pharmaceutical Inc.
15.5. Biotest AG
15.6. Bioverativ Therapeutics, Inc.
15.7. CSL Behring
15.8. Grifols, S.A.
15.9. Kedrion Biopharma
15.10. LFB S.A.
15.11. Novo Nordisk A/S
15.12. Octapharma AG
15.13. Pfizer Inc.
15.14. Prothya Biosolutions
15.15. Sanquin
15.16. Shanghai RAAS
15.17. Takeda Pharmaceutical Company Limited
15.18. uniQure N.V.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Factor IX Complex Concentrate Market, Years Considered for the Study
FIGURE 2. Global Factor IX Complex Concentrate Market, Research Design
FIGURE 3. Global Factor IX Complex Concentrate Market, Research Framework
FIGURE 4. Global Factor IX Complex Concentrate Market, Data Triangulation
FIGURE 5. Global Factor IX Complex Concentrate Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Factor IX Complex Concentrate Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Factor IX Complex Concentrate Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Factor IX Complex Concentrate Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 9. Global Factor IX Complex Concentrate Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Factor IX Complex Concentrate Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 11. Global Factor IX Complex Concentrate Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Factor IX Complex Concentrate Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Factor IX Complex Concentrate Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Factor IX Complex Concentrate Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Factor IX Complex Concentrate Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Factor IX Complex Concentrate Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Factor IX Complex Concentrate Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Factor IX Complex Concentrate Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Factor IX Complex Concentrate Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Factor IX Complex Concentrate Market Segmentation & Coverage
TABLE 2. Global Factor IX Complex Concentrate Market Size, 2017-2032 (USD Million)
TABLE 3. Global Factor IX Complex Concentrate Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Extended Half Life Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Extended Half Life Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Extended Half Life Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Albumin Fusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Albumin Fusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Albumin Fusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Fc Fusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Fc Fusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Fc Fusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Pegylated Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Pegylated Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Pegylated Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Standard Half Life Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Standard Half Life Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Standard Half Life Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Plasma Derived Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Plasma Derived Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Plasma Derived Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Factor Ix Complex Concentrate Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Factor Ix Complex Concentrate Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Factor Ix Complex Concentrate Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Prothrombin Complex Concentrate Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Prothrombin Complex Concentrate Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Prothrombin Complex Concentrate Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Recombinant Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Recombinant Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Recombinant Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Factor IX Complex Concentrate Market Size, by Indication, 2017-2032 (USD Million)
TABLE 32. Global On Demand Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global On Demand Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global On Demand Treatment Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Major Bleeds Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Major Bleeds Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Major Bleeds Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Gastrointestinal Bleeds Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Gastrointestinal Bleeds Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Gastrointestinal Bleeds Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Intracranial Hemorrhage Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Intracranial Hemorrhage Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Intracranial Hemorrhage Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Joint Bleeds Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Joint Bleeds Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Joint Bleeds Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Minor Bleeds Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Minor Bleeds Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Minor Bleeds Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Perioperative Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Perioperative Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Perioperative Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Prophylaxis Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Prophylaxis Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Prophylaxis Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Primary Prophylaxis Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Primary Prophylaxis Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Primary Prophylaxis Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Secondary Prophylaxis Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Secondary Prophylaxis Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Secondary Prophylaxis Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Factor IX Complex Concentrate Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 63. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Inpatient Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Inpatient Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Inpatient Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Outpatient Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Outpatient Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Outpatient Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Community Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Community Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Community Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Mail Order Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Mail Order Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Mail Order Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Factor IX Complex Concentrate Market Size, by End User, 2017-2032 (USD Million)
TABLE 82. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Ambulatory Infusion Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Ambulatory Infusion Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Ambulatory Infusion Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global General Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global General Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global General Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Hemophilia Treatment Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Hemophilia Treatment Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Hemophilia Treatment Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Comprehensive Care Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Comprehensive Care Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Comprehensive Care Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Specialized Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Specialized Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Specialized Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Home Care Settings Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Home Care Settings Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Home Care Settings Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Caregiver Administration Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Caregiver Administration Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Caregiver Administration Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Self Infusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Self Infusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Self Infusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Secondary Care Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Secondary Care Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Secondary Care Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Tertiary Care Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Tertiary Care Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Tertiary Care Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Factor IX Complex Concentrate Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Asia-Pacific Factor IX Complex Concentrate Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Asia-Pacific Factor IX Complex Concentrate Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 121. Asia-Pacific Factor IX Complex Concentrate Market Size, by Extended Half Life, 2017-2032 (USD Million)
TABLE 122. Asia-Pacific Factor IX Complex Concentrate Market Size, by Standard Half Life, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific Factor IX Complex Concentrate Market Size, by Plasma Derived, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific Factor IX Complex Concentrate Market Size, by Indication, 2017-2032 (USD Million)
TABLE 125. Asia-Pacific Factor IX Complex Concentrate Market Size, by On Demand Treatment, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific Factor IX Complex Concentrate Market Size, by Major Bleeds, 2017-2032 (USD Million)
TABLE 127. Asia-Pacific Factor IX Complex Concentrate Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 128. Asia-Pacific Factor IX Complex Concentrate Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 129. Asia-Pacific Factor IX Complex Concentrate Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 130. Asia-Pacific Factor IX Complex Concentrate Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 131. Asia-Pacific Factor IX Complex Concentrate Market Size, by End User, 2017-2032 (USD Million)
TABLE 132. Asia-Pacific Factor IX Complex Concentrate Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 133. Asia-Pacific Factor IX Complex Concentrate Market Size, by Hemophilia Treatment Centers, 2017-2032 (USD Million)
TABLE 134. Asia-Pacific Factor IX Complex Concentrate Market Size, by Home Care Settings, 2017-2032 (USD Million)
TABLE 135. Asia-Pacific Factor IX Complex Concentrate Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 136. North America Factor IX Complex Concentrate Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. North America Factor IX Complex Concentrate Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 138. North America Factor IX Complex Concentrate Market Size, by Extended Half Life, 2017-2032 (USD Million)
TABLE 139. North America Factor IX Complex Concentrate Market Size, by Standard Half Life, 2017-2032 (USD Million)
TABLE 140. North America Factor IX Complex Concentrate Market Size, by Plasma Derived, 2017-2032 (USD Million)
TABLE 141. North America Factor IX Complex Concentrate Market Size, by Indication, 2017-2032 (USD Million)
TABLE 142. North America Factor IX Complex Concentrate Market Size, by On Demand Treatment, 2017-2032 (USD Million)
TABLE 143. North America Factor IX Complex Concentrate Market Size, by Major Bleeds, 2017-2032 (USD Million)
TABLE 144. North America Factor IX Complex Concentrate Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 145. North America Factor IX Complex Concentrate Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 146. North America Factor IX Complex Concentrate Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 147. North America Factor IX Complex Concentrate Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 148. North America Factor IX Complex Concentrate Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. North America Factor IX Complex Concentrate Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 150. North America Factor IX Complex Concentrate Market Size, by Hemophilia Treatment Centers, 2017-2032 (USD Million)
TABLE 151. North America Factor IX Complex Concentrate Market Size, by Home Care Settings, 2017-2032 (USD Million)
TABLE 152. North America Factor IX Complex Concentrate Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 153. Latin America Factor IX Complex Concentrate Market Size, by Region, 2017-2032 (USD Million)
TABLE 154. Latin America Factor IX Complex Concentrate Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 155. Latin America Factor IX Complex Concentrate Market Size, by Extended Half Life, 2017-2032 (USD Million)
TABLE 156. Latin America Factor IX Complex Concentrate Market Size, by Standard Half Life, 2017-2032 (USD Million)
TABLE 157. Latin America Factor IX Complex Concentrate Market Size, by Plasma Derived, 2017-2032 (USD Million)
TABLE 158. Latin America Factor IX Complex Concentrate Market Size, by Indication, 2017-2032 (USD Million)
TABLE 159. Latin America Factor IX Complex Concentrate Market Size, by On Demand Treatment, 2017-2032 (USD Million)
TABLE 160. Latin America Factor IX Complex Concentrate Market Size, by Major Bleeds, 2017-2032 (USD Million)
TABLE 161. Latin America Factor IX Complex Concentrate Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 162. Latin America Factor IX Complex Concentrate Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 163. Latin America Factor IX Complex Concentrate Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 164. Latin America Factor IX Complex Concentrate Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 165. Latin America Factor IX Complex Concentrate Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. Latin America Factor IX Complex Concentrate Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 167. Latin America Factor IX Complex Concentrate Market Size, by Hemophilia Treatment Centers, 2017-2032 (USD Million)
TABLE 168. Latin America Factor IX Complex Concentrate Market Size, by Home Care Settings, 2017-2032 (USD Million)
TABLE 169. Latin America Factor IX Complex Concentrate Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 170. Europe Factor IX Complex Concentrate Market Size, by Region, 2017-2032 (USD Million)
TABLE 171. Europe Factor IX Complex Concentrate Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 172. Europe Factor IX Complex Concentrate Market Size, by Extended Half Life, 2017-2032 (USD Million)
TABLE 173. Europe Factor IX Complex Concentrate Market Size, by Standard Half Life, 2017-2032 (USD Million)
TABLE 174. Europe Factor IX Complex Concentrate Market Size, by Plasma Derived, 2017-2032 (USD Million)
TABLE 175. Europe Factor IX Complex Concentrate Market Size, by Indication, 2017-2032 (USD Million)
TABLE 176. Europe Factor IX Complex Concentrate Market Size, by On Demand Treatment, 2017-2032 (USD Million)
TABLE 177. Europe Factor IX Complex Concentrate Market Size, by Major Bleeds, 2017-2032 (USD Million)
TABLE 178. Europe Factor IX Complex Concentrate Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 179. Europe Factor IX Complex Concentrate Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 180. Europe Factor IX Complex Concentrate Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 181. Europe Factor IX Complex Concentrate Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 182. Europe Factor IX Complex Concentrate Market Size, by End User, 2017-2032 (USD Million)
TABLE 183. Europe Factor IX Complex Concentrate Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 184. Europe Factor IX Complex Concentrate Market Size, by Hemophilia Treatment Centers, 2017-2032 (USD Million)
TABLE 185. Europe Factor IX Complex Concentrate Market Size, by Home Care Settings, 2017-2032 (USD Million)
TABLE 186. Europe Factor IX Complex Concentrate Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 187. Middle East Factor IX Complex Concentrate Market Size, by Region, 2017-2032 (USD Million)
TABLE 188. Middle East Factor IX Complex Concentrate Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 189. Middle East Factor IX Complex Concentrate Market Size, by Extended Half Life, 2017-2032 (USD Million)
TABLE 190. Middle East Factor IX Complex Concentrate Market Size, by Standard Half Life, 2017-2032 (USD Million)
TABLE 191. Middle East Factor IX Complex Concentrate Market Size, by Plasma Derived, 2017-2032 (USD Million)
TABLE 192. Middle East Factor IX Complex Concentrate Market Size, by Indication, 2017-2032 (USD Million)
TABLE 193. Middle East Factor IX Complex Concentrate Market Size, by On Demand Treatment, 2017-2032 (USD Million)
TABLE 194. Middle East Factor IX Complex Concentrate Market Size, by Major Bleeds, 2017-2032 (USD Million)
TABLE 195. Middle East Factor IX Complex Concentrate Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 196. Middle East Factor IX Complex Concentrate Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 197. Middle East Factor IX Complex Concentrate Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 198. Middle East Factor IX Complex Concentrate Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 199. Middle East Factor IX Complex Concentrate Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. Middle East Factor IX Complex Concentrate Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 201. Middle East Factor IX Complex Concentrate Market Size, by Hemophilia Treatment Centers, 2017-2032 (USD Million)
TABLE 202. Middle East Factor IX Complex Concentrate Market Size, by Home Care Settings, 2017-2032 (USD Million)
TABLE 203. Middle East Factor IX Complex Concentrate Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 204. Africa Factor IX Complex Concentrate Market Size, by Region, 2017-2032 (USD Million)
TABLE 205. Africa Factor IX Complex Concentrate Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 206. Africa Factor IX Complex Concentrate Market Size, by Extended Half Life, 2017-2032 (USD Million)
TABLE 207. Africa Factor IX Complex Concentrate Market Size, by Standard Half Life, 2017-2032 (USD Million)
TABLE 208. Africa Factor IX Complex Concentrate Market Size, by Plasma Derived, 2017-2032 (USD Million)
TABLE 209. Africa Factor IX Complex Concentrate Market Size, by Indication, 2017-2032 (USD Million)
TABLE 210. Africa Factor IX Complex Concentrate Market Size, by On Demand Treatment, 2017-2032 (USD Million)
TABLE 211. Africa Factor IX Complex Concentrate Market Size, by Major Bleeds, 2017-2032 (USD Million)
TABLE 212. Africa Factor IX Complex Concentrate Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 213. Africa Factor IX Complex Concentrate Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 214. Africa Factor IX Complex Concentrate Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 215. Africa Factor IX Complex Concentrate Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 216. Africa Factor IX Complex Concentrate Market Size, by End User, 2017-2032 (USD Million)
TABLE 217. Africa Factor IX Complex Concentrate Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 218. Africa Factor IX Complex Concentrate Market Size, by Hemophilia Treatment Centers, 2017-2032 (USD Million)
TABLE 219. Africa Factor IX Complex Concentrate Market Size, by Home Care Settings, 2017-2032 (USD Million)
TABLE 220. Africa Factor IX Complex Concentrate Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 221. Global Factor IX Complex Concentrate Market Size, by Group, 2017-2032 (USD Million)
TABLE 222. ASEAN Factor IX Complex Concentrate Market Size, by Group, 2017-2032 (USD Million)
TABLE 223. ASEAN Factor IX Complex Concentrate Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 224. ASEAN Factor IX Complex Concentrate Market Size, by Extended Half Life, 2017-2032 (USD Million)
TABLE 225. ASEAN Factor IX Complex Concentrate Market Size, by Standard Half Life, 2017-2032 (USD Million)
TABLE 226. ASEAN Factor IX Complex Concentrate Market Size, by Plasma Derived, 2017-2032 (USD Million)
TABLE 227. ASEAN Factor IX Complex Concentrate Market Size, by Indication, 2017-2032 (USD Million)
TABLE 228. ASEAN Factor IX Complex Concentrate Market Size, by On Demand Treatment, 2017-2032 (USD Million)
TABLE 229. ASEAN Factor IX Complex Concentrate Market Size, by Major Bleeds, 2017-2032 (USD Million)
TABLE 230. ASEAN Factor IX Complex Concentrate Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 231. ASEAN Factor IX Complex Concentrate Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 232. ASEAN Factor IX Complex Concentrate Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 233. ASEAN Factor IX Complex Concentrate Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 234. ASEAN Factor IX Complex Concentrate Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. ASEAN Factor IX Complex Concentrate Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 236. ASEAN Factor IX Complex Concentrate Market Size, by Hemophilia Treatment Centers, 2017-2032 (USD Million)
TABLE 237. ASEAN Factor IX Complex Concentrate Market Size, by Home Care Settings, 2017-2032 (USD Million)
TABLE 238. ASEAN Factor IX Complex Concentrate Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 239. GCC Factor IX Complex Concentrate Market Size, by Group, 2017-2032 (USD Million)
TABLE 240. GCC Factor IX Complex Concentrate Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 241. GCC Factor IX Complex Concentrate Market Size, by Extended Half Life, 2017-2032 (USD Million)
TABLE 242. GCC Factor IX Complex Concentrate Market Size, by Standard Half Life, 2017-2032 (USD Million)
TABLE 243. GCC Factor IX Complex Concentrate Market Size, by Plasma Derived, 2017-2032 (USD Million)
TABLE 244. GCC Factor IX Complex Concentrate Market Size, by Indication, 2017-2032 (USD Million)
TABLE 245. GCC Factor IX Complex Concentrate Market Size, by On Demand Treatment, 2017-2032 (USD Million)
TABLE 246. GCC Factor IX Complex Concentrate Market Size, by Major Bleeds, 2017-2032 (USD Million)
TABLE 247. GCC Factor IX Complex Concentrate Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 248. GCC Factor IX Complex Concentrate Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 249. GCC Factor IX Complex Concentrate Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 250. GCC Factor IX Complex Concentrate Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 251. GCC Factor IX Complex Concentrate Market Size, by End User, 2017-2032 (USD Million)
TABLE 252. GCC Factor IX Complex Concentrate Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 253. GCC Factor IX Complex Concentrate Market Size, by Hemophilia Treatment Centers, 2017-2032 (USD Million)
TABLE 254. GCC Factor IX Complex Concentrate Market Size, by Home Care Settings, 2017-2032 (USD Million)
TABLE 255. GCC Factor IX Complex Concentrate Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 256. European Union Factor IX Complex Concentrate Market Size, by Group, 2017-2032 (USD Million)
TABLE 257. European Union Factor IX Complex Concentrate Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 258. European Union Factor IX Complex Concentrate Market Size, by Extended Half Life, 2017-2032 (USD Million)
TABLE 259. European Union Factor IX Complex Concentrate Market Size, by Standard Half Life, 2017-2032 (USD Million)
TABLE 260. European Union Factor IX Complex Concentrate Market Size, by Plasma Derived, 2017-2032 (USD Million)
TABLE 261. European Union Factor IX Complex Concentrate Market Size, by Indication, 2017-2032 (USD Million)
TABLE 262. European Union Factor IX Complex Concentrate Market Size, by On Demand Treatment, 2017-2032 (USD Million)
TABLE 263. European Union Factor IX Complex Concentrate Market Size, by Major Bleeds, 2017-2032 (USD Million)
TABLE 264. European Union Factor IX Complex Concentrate Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 265. European Union Factor IX Complex Concentrate Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 266. European Union Factor IX Complex Concentrate Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 267. European Union Factor IX Complex Concentrate Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 268. European Union Factor IX Complex Concentrate Market Size, by End User, 2017-2032 (USD Million)
TABLE 269. European Union Factor IX Complex Concentrate Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 270. European Union Factor IX Complex Concentrate Market Size, by Hemophilia Treatment Centers, 2017-2032 (USD Million)
TABLE 271. European Union Factor IX Complex Concentrate Market Size, by Home Care Settings, 2017-2032 (USD Million)
TABLE 272. European Union Factor IX Complex Concentrate Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 273. BRICS Factor IX Complex Concentrate Market Size, by Group, 2017-2032 (USD Million)
TABLE 274. BRICS Factor IX Complex Concentrate Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 275. BRICS Factor IX Complex Concentrate Market Size, by Extended Half Life, 2017-2032 (USD Million)
TABLE 276. BRICS Factor IX Complex Concentrate Market Size, by Standard Half Life, 2017-2032 (USD Million)
TABLE 277. BRICS Factor IX Complex Concentrate Market Size, by Plasma Derived, 2017-2032 (USD Million)
TABLE 278. BRICS Factor IX Complex Concentrate Market Size, by Indication, 2017-2032 (USD Million)
TABLE 279. BRICS Factor IX Complex Concentrate Market Size, by On Demand Treatment, 2017-2032 (USD Million)
TABLE 280. BRICS Factor IX Complex Concentrate Market Size, by Major Bleeds, 2017-2032 (USD Million)
TABLE 281. BRICS Factor IX Complex Concentrate Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 282. BRICS Factor IX Complex Concentrate Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 283. BRICS Factor IX Complex Concentrate Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 284. BRICS Factor IX Complex Concentrate Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 285. BRICS Factor IX Complex Concentrate Market Size, by End User, 2017-2032 (USD Million)
TABLE 286. BRICS Factor IX Complex Concentrate Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 287. BRICS Factor IX Complex Concentrate Market Size, by Hemophilia Treatment Centers, 2017-2032 (USD Million)
TABLE 288. BRICS Factor IX Complex Concentrate Market Size, by Home Care Settings, 2017-2032 (USD Million)
TABLE 289. BRICS Factor IX Complex Concentrate Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 290. G7 Factor IX Complex Concentrate Market Size, by Group, 2017-2032 (USD Million)
TABLE 291. G7 Factor IX Complex Concentrate Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 292. G7 Factor IX Complex Concentrate Market Size, by Extended Half Life, 2017-2032 (USD Million)
TABLE 293. G7 Factor IX Complex Concentrate Market Size, by Standard Half Life, 2017-2032 (USD Million)
TABLE 294. G7 Factor IX Complex Concentrate Market Size, by Plasma Derived, 2017-2032 (USD Million)
TABLE 295. G7 Factor IX Complex Concentrate Market Size, by Indication, 2017-2032 (USD Million)
TABLE 296. G7 Factor IX Complex Concentrate Market Size, by On Demand Treatment, 2017-2032 (USD Million)
TABLE 297. G7 Factor IX Complex Concentrate Market Size, by Major Bleeds, 2017-2032 (USD Million)
TABLE 298. G7 Factor IX Complex Concentrate Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 299. G7 Factor IX Complex Concentrate Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 300. G7 Factor IX Complex Concentrate Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 301. G7 Factor IX Complex Concentrate Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 302. G7 Factor IX Complex Concentrate Market Size, by End User, 2017-2032 (USD Million)
TABLE 303. G7 Factor IX Complex Concentrate Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 304. G7 Factor IX Complex Concentrate Market Size, by Hemophilia Treatment Centers, 2017-2032 (USD Million)
TABLE 305. G7 Factor IX Complex Concentrate Market Size, by Home Care Settings, 2017-2032 (USD Million)
TABLE 306. G7 Factor IX Complex Concentrate Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 307. NATO Factor IX Complex Concentrate Market Size, by Group, 2017-2032 (USD Million)
TABLE 308. NATO Factor IX Complex Concentrate Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 309. NATO Factor IX Complex Concentrate Market Size, by Extended Half Life, 2017-2032 (USD Million)
TABLE 310. NATO Factor IX Complex Concentrate Market Size, by Standard Half Life, 2017-2032 (USD Million)
TABLE 311. NATO Factor IX Complex Concentrate Market Size, by Plasma Derived, 2017-2032 (USD Million)
TABLE 312. NATO Factor IX Complex Concentrate Market Size, by Indication, 2017-2032 (USD Million)
TABLE 313. NATO Factor IX Complex Concentrate Market Size, by On Demand Treatment, 2017-2032 (USD Million)
TABLE 314. NATO Factor IX Complex Concentrate Market Size, by Major Bleeds, 2017-2032 (USD Million)
TABLE 315. NATO Factor IX Complex Concentrate Market Size, by Prophylaxis, 2017-2032 (USD Million)
TABLE 316. NATO Factor IX Complex Concentrate Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 317. NATO Factor IX Complex Concentrate Market Size, by Hospital Pharmacies, 2017-2032 (USD Million)
TABLE 318. NATO Factor IX Complex Concentrate Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
TABLE 319. NATO Factor IX Complex Concentrate Market Size, by End User, 2017-2032 (USD Million)
TABLE 320. NATO Factor IX Complex Concentrate Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 321. NATO Factor IX Complex Concentrate Market Size, by Hemophilia Treatment Centers, 2017-2032 (USD Million)
TABLE 322. NATO Factor IX Complex Concentrate Market Size, by Home Care Settings, 2017-2032 (USD Million)
TABLE 323. NATO Factor IX Complex Concentrate Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 324. Global Factor IX Complex Concentrate Market Size, by Country, 2017-2032 (USD Million)
TABLE 325. United States Factor IX Complex Concentrate Market Size, 2017-2032 (USD Million)
TABLE 326. United States Factor IX Complex Concentrate Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 327. United States Factor IX Complex Concentrate Market Size, by Extended Half Life, 2017-2032 (USD Million)
TABLE 328. United States Factor IX Complex Concentrate Market Size, by Standard Half Life, 2017-2032 (USD Million)
TABLE 329. United States Factor IX Complex Concentrate Market Size, by Plasma Derived, 2017-2032 (USD Million)
TABLE 330. United States Factor IX Complex Concentrate Market Size, by Indication, 2017-2032 (USD Million)
TABLE 331. United States Factor IX Complex Concentrate Market Size, by On Demand Treatment, 2017-2032 (USD Million)
TABLE 332. United States Factor IX Complex Concentrate Market Size, by Major Bleeds, 2017-2032 (USD Million)
TABL

Companies Mentioned

  • Aptevo BioTherapeutics LLC
  • Bayer AG
  • Bio Products Laboratory
  • BioMarin Pharmaceutical Inc.
  • Biotest AG
  • Bioverativ Therapeutics, Inc.
  • CSL Behring
  • Grifols, S.A.
  • Kedrion Biopharma
  • LFB S.A.
  • Novo Nordisk A/S
  • Octapharma AG
  • Pfizer Inc.
  • Prothya Biosolutions
  • Sanquin
  • Shanghai RAAS
  • Takeda Pharmaceutical Company Limited
  • uniQure N.V.

Related Topics

Related Reports

Hemophilia Treatment Market - Global Forecast 2026-2032 - Product Image

Hemophilia Treatment Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Alphanine SD Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Image

Alphanine SD Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • 250 Pages
  • Global
From
Coagulation Factor Deficiency Market Report 2026 - Product Image

Coagulation Factor Deficiency Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Hemophilia B - Pipeline Insight, 2026 - Product Image

Hemophilia B - Pipeline Insight, 2026

  • Clinical Trials
  • 80 Pages
  • Global
From
Hemophilia B - Market Insight, Epidemiology, and Market Forecast - 2036 - Product Image

Hemophilia B - Market Insight, Epidemiology, and Market Forecast - 2036

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.